Ulcerative colitis — the surgical perspective
Ulcerative colitis is a chronic inflammatory disease confined to the colon and rectum. It differs from Crohn's disease in one respect with far-reaching surgical consequences: because it affects only the large bowel, and only its inner lining, removing the colon removes the disease. Surgery for ulcerative colitis is therefore curative in a way it never is for Crohn's. The questions are when to operate, and which of the reconstructive options serves a particular patient best — a decision that deserves considerably more discussion than it often receives.
How it develops
As in Crohn's disease, the mechanism is a dysregulated immune response to the intestinal microbiota in a genetically susceptible person. The differences in pattern reflect differences in the underlying biology:
- Barrier defect — the defect appears to be principally in the epithelial barrier and the protective mucus layer, which is thinner and more penetrable in ulcerative colitis. Genes governing mucin production and epithelial integrity, such as HNF4A and ECM1, are implicated.
- Immune response — a Th2-like response predominates, driven in part by interleukin-13, in contrast to the Th1/Th17 pattern of Crohn's.
- Pattern of inflammation — the inflammation is continuous, begins invariably at the rectum and extends proximally for a variable distance, and is confined to the mucosa and submucosa. It does not go through the wall.
Two consequences follow. Because inflammation is superficial, strictures and fistulas are not features — a stricture in ulcerative colitis raises the suspicion of cancer until proved otherwise. And because it is continuous from the rectum, disease extent can be described simply: proctitis, left-sided colitis, or extensive colitis/pancolitis.
Curiously and consistently, smoking appears protective in ulcerative colitis, and the disease not uncommonly presents shortly after a person stops smoking. This is not a reason to smoke, and nicotine treatment has proved disappointing, but it is a real observation and patients often notice it themselves.
A serious complication of severe disease is toxic megacolon: inflammation extends into the muscle layer, paralysing it; the colon dilates, thins, and is at risk of perforation. It is a surgical emergency and a situation where delay is dangerous.
Cancer risk rises with duration of disease, extent of involvement, severity of inflammation, the presence of pseudopolyps, a family history, and coexisting primary sclerosing cholangitis. Cancer in colitis arises from flat dysplasia rather than from polyps, which is why surveillance uses chromoendoscopy and targeted biopsies rather than simply looking for lumps.
Symptoms
- Bloody diarrhoea — the cardinal symptom
- mucus and pus in the stool
- urgency and tenesmus — a constant sensation of needing to open the bowels, which can be profoundly disabling
- nocturnal bowel motions
- crampy lower abdominal pain, typically relieved by defecation
- in proctitis, paradoxical constipation with rectal bleeding
- systemic features in severe disease: fever, tachycardia, anaemia, weight loss
- extraintestinal features — arthritis, erythema nodosum, pyoderma gangrenosum, uveitis and episcleritis, and primary sclerosing cholangitis, which requires its own monitoring and carries both a cholangiocarcinoma and a heightened colorectal cancer risk
Acute severe colitis is defined by the Truelove and Witts criteria: six or more bloody stools daily with any of fever, tachycardia, anaemia or a raised ESR. It is a medical emergency requiring hospital admission, not outpatient management.
How the diagnosis is made
- Stool cultures and Clostridioides difficile testing — infection both mimics and precipitates flares, and must be excluded.
- Faecal calprotectin — distinguishes inflammatory from functional symptoms and monitors activity.
- Colonoscopy with biopsies — showing continuous inflammation from the rectum, loss of vascular pattern, granularity, friability and ulceration; histology shows crypt architectural distortion, crypt abscesses and mucosal-limited inflammation. In acute severe disease, flexible sigmoidoscopy without full preparation is safer than full colonoscopy.
- Abdominal X-ray in acute severe colitis, to assess colonic diameter and detect toxic dilatation.
- Blood tests for inflammation, anaemia and nutritional state.
Medical treatment
Led by gastroenterology. 5-aminosalicylates are the mainstay for mild to moderate disease, both oral and topical, and topical treatment is consistently under-used despite being highly effective for distal disease. Corticosteroids induce remission in flares. Thiopurines, biological agents (anti-TNF, anti-integrin, anti-interleukin-12/23) and small molecules (JAK inhibitors, S1P modulators) maintain remission. Acute severe colitis is treated with intravenous steroids and, if there is no response within three days, with rescue therapy — infliximab or ciclosporin — with surgery if that fails.
The critical point in acute severe colitis is timing. Delaying surgery in a patient failing medical rescue therapy increases mortality substantially. Daily joint review by physician and surgeon is standard, and the surgeon should meet the patient early rather than at the point of crisis.
Surgery
Indications
- Emergency — toxic megacolon, perforation, massive haemorrhage, or acute severe colitis failing medical treatment.
- Elective — disease refractory to medical therapy or requiring unacceptable doses of steroids, intolerable side effects, growth failure in children, and dysplasia or cancer.
Emergency surgery: subtotal colectomy
The correct emergency operation is subtotal colectomy with end ileostomy, leaving the rectal stump in place. It removes the diseased colon and the acute threat while leaving the definitive reconstruction to be decided later, when the patient is well, off steroids, nourished, and able to participate in the decision. Attempting a pouch in an acutely unwell patient on high-dose steroids is a recognised error.
Definitive options
Once recovered, three reconstructive paths exist, and the choice is genuinely the patient's to make with full information:
- Ileal pouch-anal anastomosis (IPAA, "J-pouch") — the ileum is fashioned into a reservoir and joined to the anal canal, restoring continence without a permanent stoma. It is usually performed in two or three stages. Expectations must be realistic: typical function is around four to eight bowel motions in twenty-four hours, including at night, with some seepage in a minority. Pouchitis — inflammation of the pouch — affects a substantial proportion at some point and usually responds to antibiotics or probiotics. Pouch failure requiring excision occurs in a small but real percentage. Fertility in women is reduced by pelvic surgery, and this should be discussed before the operation, with the option of deferring the pouch until after childbearing.
- Proctocolectomy with permanent end ileostomy — a single definitive operation with reliable function, no pouchitis, and high patient satisfaction in long-term studies. It is frequently presented as the lesser option when it is simply a different one, and for many patients — particularly older patients, those with poor sphincter function, and those who value predictability — it is the better choice.
- Ileorectal anastomosis — preserving the rectum, occasionally appropriate where the rectum is relatively spared and fertility is a priority, but it leaves diseased rectum requiring surveillance.
Most of these operations are performed laparoscopically or robotically.
Cancer and dysplasia
Colonoscopic surveillance begins some eight years after the onset of symptoms in extensive colitis, at intervals determined by risk, and immediately on diagnosis where primary sclerosing cholangitis coexists. Chromoendoscopy with targeted biopsies has replaced random biopsy sampling. Confirmed high-grade dysplasia, or dysplasia not amenable to endoscopic removal, is an indication for colectomy.
Recovery
After laparoscopic subtotal colectomy, hospital stay is typically five to seven days. Pouch surgery involves a longer overall course across its stages, and pouch function improves progressively over the first twelve months — patients should be warned that early function is not final function. Stoma nurse support is central throughout, both for temporary and permanent stomas.
Follow-up
For those on medical treatment, monitoring of disease activity, drug levels and toxicity, bone health, and colonoscopic surveillance. After pouch surgery, review of function, treatment of pouchitis, and endoscopic surveillance of the pouch and any retained rectal cuff.
When to seek an opinion
Bloody diarrhoea lasting more than a few days requires assessment. Six or more bloody stools a day, with fever, a racing pulse or feeling systemically unwell, requires hospital admission rather than an outpatient appointment. Severe abdominal pain with distension in known colitis is an emergency.
Common questions
Can surgery cure ulcerative colitis?
Yes. Unlike Crohn's disease, ulcerative colitis affects only the large bowel, so removing it removes the disease. That is a genuine cure, and it is a meaningful difference between the two conditions.
If it can be cured, why not operate straight away?
Because medication controls the disease well for many people, and the operation is a major one with lasting consequences for bowel function or the need for a stoma. Surgery is advised when medication is not controlling the disease, when the side effects are unacceptable, when precancerous changes appear, or in an emergency.
Will I definitely need a bag?
Not necessarily permanently. Many people have an internal pouch made from small bowel, which restores normal continence without a bag, although it usually involves a temporary stoma along the way. Others choose a permanent stoma, and long-term studies show high satisfaction with that choice. Both are legitimate, and the decision should be yours with full information about each.
What is a J-pouch really like?
Typically four to eight bowel motions in twenty-four hours, including waking once or twice at night, with stool that is soft rather than formed. Some people experience occasional leakage, and a proportion develop inflammation of the pouch at some point, which usually responds to antibiotics. Function improves over the first year. Most people are satisfied, but knowing the realistic picture beforehand matters.
Will it affect my fertility?
Pouch surgery in women reduces fertility, because of adhesions around the fallopian tubes from operating in the pelvis. This is important enough that some women choose to delay the pouch until after having children, keeping a temporary stoma in the meantime. It should be raised before surgery, not afterwards.
I stopped smoking and then developed colitis. Is that connected?
It is a well-documented pattern — ulcerative colitis quite often appears shortly after stopping smoking, and smoking does appear to have a protective effect in this specific condition. This is not a reason to start again, since the harms of smoking far outweigh it, and nicotine treatment has not proved a useful substitute.
Do I have a higher risk of bowel cancer?
Yes, if the disease is extensive and long-standing, and the risk relates closely to how much inflammation there has been over the years. This is why regular colonoscopies are recommended after several years of disease, using dye-spray techniques that show up flat changes not visible otherwise. Keeping inflammation well controlled also reduces the risk.
Why is a narrowing in the bowel taken so seriously in colitis?
Because ulcerative colitis affects only the surface lining and does not normally cause scarring narrowings, unlike Crohn's disease. A narrowing therefore has to be assumed to be a cancer until it has been properly examined and proved otherwise.
Related conditions
Other conditions of the colon & rectum covered on this site:
- Colon cancer
- Rectal cancer
- Bowel polyps (colorectal polyps)
- Diverticular disease and diverticulitis
- Crohn's disease — the surgical perspective
- Large bowel obstruction and volvulus
- Appendicitis
- Hereditary bowel cancer syndromes (Lynch syndrome and FAP)
This page provides general information and does not replace an individual medical consultation. Ulcerative colitis is managed jointly with a gastroenterologist, and treatment is decided for each patient individually.